Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions
| Tracking Information | |
|---|---|
| First Received Date ICMJE | July 26, 2011 |
| Last Updated Date | July 26, 2011 |
| Start Date ICMJE | January 2008 |
| Primary Completion Date | December 2010 (final data collection date for primary outcome measure) |
| Current Primary Outcome Measures ICMJE | Not Provided |
| Original Primary Outcome Measures ICMJE | Not Provided |
| Change History | No Changes Posted |
| Current Secondary Outcome Measures ICMJE | Not Provided |
| Original Secondary Outcome Measures ICMJE | Not Provided |
| Current Other Outcome Measures ICMJE | Not Provided |
| Original Other Outcome Measures ICMJE | Not Provided |
| Descriptive Information | |
| Brief Title ICMJE | Rates of Positive Basal Cell Carcinomas (BCCs) in Re-excisions |
| Official Title ICMJE | Rates of Positive BCCs in Re-excisions |
| Brief Summary | Basal Cell Carcinoma (BCC) is the most common malignant growth in the world. Treatment is primarily surgical with the goal of excising the growth in its entirety. When pathology results show that this has not been achieved, a re-excision is routinely performed. This study examines retrospectively the percentage of re-excisions of BCC that actually proved to be positive (exhibited growth) among those re-excisions performed at Rambam Healthcare Campus and Zvulun Community Medical Center during the years 2008-10. |
| Detailed Description | Not Provided |
| Study Type ICMJE | Observational |
| Study Design ICMJE | Observational Model: Cohort Time Perspective: Retrospective |
| Target Follow-Up Duration | Not Provided |
| Biospecimen | Not Provided |
| Sampling Method | Probability Sample |
| Study Population | All patients that underwent an incomplete BCC excision during the years 2008-2010. |
| Condition ICMJE | Basal Cell Carcinoma |
| Intervention ICMJE | Not Provided |
| Study Group/Cohort (s) | Not Provided |
| Publications * | Not Provided |
|
* Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline. |
|
| Recruitment Information | |
| Recruitment Status ICMJE | Completed |
| Estimated Enrollment ICMJE | 600 |
| Completion Date | February 2011 |
| Primary Completion Date | December 2010 (final data collection date for primary outcome measure) |
| Eligibility Criteria ICMJE | Inclusion Criteria: All patients that underwent an incomplete BCC excision during the years 2008-2010. Exclusion Criteria: Patients that underwent an incomplete BCC excision and were subsequently referred to undergo a MOHS procedure. |
| Gender | Both |
| Ages | 18 Years and older |
| Accepts Healthy Volunteers | No |
| Contacts ICMJE | Contact information is only displayed when the study is recruiting subjects |
| Location Countries ICMJE | Not Provided |
| Administrative Information | |
| NCT Number ICMJE | NCT01403480 |
| Other Study ID Numbers ICMJE | 0064-11-RMB-CTIL |
| Has Data Monitoring Committee | No |
| Responsible Party | Prof. Yehuda Ullmann, Head, Plastic and Reconstructive Surgery Department, Rambam Healthcare Campus |
| Study Sponsor ICMJE | Rambam Health Care Campus |
| Collaborators ICMJE | Not Provided |
| Investigators ICMJE | Not Provided |
| Information Provided By | Rambam Health Care Campus |
| Verification Date | February 2011 |
|
ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP |
|